Showing results (91-100 of 102) with videos related to

Sort By:
Pageof 11
Bone Marrow Transplantation|February 9, 2016
Allogeneic hematopoietic cell transplantation as curative therapy for non-transformed follicular lymphomasF Heinzelmann, W Bethge, D W Beelen, et al.
Blood|January 12, 2001
Cidofovir for cytomegalovirus infection and disease in allogeneic stem cell transplant recipients. The Infectious Diseases Working Party of the European Group for Blood and Marrow TransplantationP Ljungman, G L Deliliers, U Platzbecker, et al.
Bone Marrow Transplantation|January 24, 2017
Risk factors for treatment failure after allogeneic transplantation of patients with CLL: a report from the European Society for Blood and Marrow TransplantationJ Schetelig, L C de Wreede, M van Gelder, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 26, 2017
Allogeneic hematopoietic cell transplantation in intermediate risk acute myeloid leukemia negative for FLT3-ITD, NPM1- or biallelic CEBPA mutationsK Heidrich, C Thiede, K Schäfer-Eckart, et al.
Leukemia|December 6, 2012
Randomized comparison of prophylactic and minimal residual disease-triggered imatinib after allogeneic stem cell transplantation for BCR-ABL1-positive acute lymphoblastic leukemiaH Pfeifer, B Wassmann, W Bethge, et al.
Leukemia|August 19, 2015
Clofarabine salvage therapy before allogeneic hematopoietic stem cell transplantation in patients with relapsed or refractory AML: results of the BRIDGE trialJ M Middeke, R Herbst, S Parmentier, et al.
Leukemia|April 18, 2008
Impact of genetic abnormalities on survival after allogeneic hematopoietic stem cell transplantation in multiple myelomaG Schilling, T Hansen, A Shimoni, et al.
Leukemia|December 2, 2014
Hematopoietic cell transplantation in patients with intermediate and high-risk AML: results from the randomized Study Alliance Leukemia (SAL) AML 2003 trialJ Schetelig, M Schaich, K Schäfer-Eckart, et al.
Bone Marrow Transplantation|April 29, 2021
Trends in allogeneic haematopoietic cell transplantation for myelofibrosis in Europe between 1995 and 2018: a CMWP of EBMT retrospective analysisD McLornan, D J Eikema, T Czerw, et al.
Blood Cancer Journal|January 16, 2016
Karyotype complexity and prognosis in acute myeloid leukemiaF Stölzel, B Mohr, M Kramer, et al.
Pageof 11